Fact CheckerSign in

NCT07454239Active, not recruiting

EPOCH-Economics and Patient Outcomes in China in Haemophilia

Source: ClinicalTrials.gov · Last updated 6 Mar 2026

Brief summary (registry, in English)

The overarching goal of the EPOCH project is to: * Support a broad and robust needs assessment in the haemophilia space in China * Measure the variability in the needs and care provision * Generate outcome data (health economic outcomes and supporting clinical and PRO data) to enable measuring the impact of different treatment modalities and different levels of treatment access PRIMARY OBJECTIVES * Determine the burden of haemophilia in China, and the determinants of its variability * Determine the costs of haemophilia care in China, and the determinants of its variability SECONDARY OBJECTIVES * Measure treatment patterns and their variability * Measure levels of access to care * Estimate the impact of haemophilia and its treatment of patients reported outcomes * Understand consistency of care by centres/geography/demographics

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
5 Jun 2025
Start date
14 Nov 2024
Primary completion date
31 Dec 2028
Lead sponsor
Institute of Hematology & Blood Diseases Hospital, China
Diseases
Haemophilia
NCT number
NCT07454239

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 14 Nov 2024 to the primary completion date, 31 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients who cannot, for any reasons (language barriers, mental incapacity, etc.) understand and answer the questions of the study questionnaires
  • Patients that cannot access internet connection or download the application

Who the study is looking for

  • Male patients, aged ≥12 years at the index date
  • Patients must be diagnosed with non-acquired severe haemophilia A or B prior to the previous 12 months
  • Patients who are able to understand and assent / consent to the study

Age in the registry: 12 Minutes to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Instiute of Hematology and Blood Diseases Hospital CAMS&PUMC
Coordinator of this site? Confirm its status
TianjinChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.